Wyeth Suggests Pristiq Could Surpass Effexor XR In Depression Market
This article was originally published in The Pink Sheet Daily
Executive Summary
Combined global market for major depressive disorder and vasomotor symptoms represents 35 million women, firm says during Goldman Sachs investor conference.